Omjjara 100 mg

Omjjara 100 mg is a medicine authorised by Swissmedic under authorisation number 69428. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 September 2024 and the authorisation is limited until 24 September 2029. ATC code L01EJ04 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 69428
  • ATC L01EJ04
  • Synthetic medicines
Authorisation data
Authorisation number69428
NameOmjjara 100 mg
Full nameOmjjara 100 mg, Filmtabletten
Authorisation holderGlaxoSmithKline AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01EJ04
First authorisation25 September 2024
Authorisation validity24 September 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Omjjara 100 mg, FilmtablettenA25 September 2024
2Omjjara 150 mg, FilmtablettenA25 September 2024
3Omjjara 200 mg, FilmtablettenA25 September 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)L01EJ0407.16.1.A
230Tablette(n)L01EJ0407.16.1.A
330Tablette(n)L01EJ0407.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Omjjara 100 mg authorised in Switzerland?

Yes. Omjjara 100 mg is authorised by Swissmedic under authorisation number 69428, data as of 01 September 2026. The authorisation is limited until 24 September 2029.

Which dispensing category does Omjjara 100 mg have?

Omjjara 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Omjjara 100 mg?

The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com